Alkermes officer proposes sale of 2,034 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Alkermes plc officer David Joseph Gaffin reported a proposed sale of 2,034 common shares, with an aggregate market value of 67,528.80 and an approximate sale date of May 4, 2026. Merrill Lynch is listed as broker, and the notice gives November 19, 2025 as the Rule 10b5-1 plan adoption or instruction date. It also lists three earlier sales of 2,034 shares each: March 2 for 59,575.86, March 3 for 60,531.84, and April 6 for 70,315.38 in gross proceeds.
Key Figures
Key Terms
Rule 10b5-1 regulatory
restricted stock unit award financial
Aggregate Market Value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.